[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI1000027T1 - Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it - Google Patents

Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it

Info

Publication number
SI1000027T1
SI1000027T1 SI9830442T SI9830442T SI1000027T1 SI 1000027 T1 SI1000027 T1 SI 1000027T1 SI 9830442 T SI9830442 T SI 9830442T SI 9830442 T SI9830442 T SI 9830442T SI 1000027 T1 SI1000027 T1 SI 1000027T1
Authority
SI
Slovenia
Prior art keywords
carbazolyloxy
propanole
methoxyphenoxy
ethylamino
preparation
Prior art date
Application number
SI9830442T
Other languages
English (en)
Slovenian (sl)
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of SI1000027T1 publication Critical patent/SI1000027T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI9830442T 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it SI1000027T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
PCT/EP1998/004475 WO1999005105A1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
EP98937576A EP1000027B1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
SI1000027T1 true SI1000027T1 (en) 2003-10-31

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830442T SI1000027T1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it

Country Status (32)

Country Link
EP (2) EP0893440A1 (xx)
JP (1) JP2001510824A (xx)
KR (1) KR100336229B1 (xx)
CN (1) CN1125047C (xx)
AR (1) AR015133A1 (xx)
AT (1) ATE236123T1 (xx)
AU (1) AU740453B2 (xx)
BR (1) BR9810776A (xx)
CA (1) CA2296637C (xx)
CZ (1) CZ296947B6 (xx)
DE (1) DE69812964T2 (xx)
DK (1) DK1000027T3 (xx)
ES (1) ES2195366T3 (xx)
HK (1) HK1029339A1 (xx)
HR (1) HRP980406A2 (xx)
HU (1) HUP0003198A3 (xx)
IL (1) IL133677A (xx)
MA (1) MA26523A1 (xx)
MY (1) MY117734A (xx)
NO (1) NO313588B1 (xx)
NZ (1) NZ502136A (xx)
PE (1) PE96999A1 (xx)
PL (1) PL191602B1 (xx)
PT (1) PT1000027E (xx)
RU (1) RU2202542C2 (xx)
SI (1) SI1000027T1 (xx)
TR (1) TR200000148T2 (xx)
TW (1) TW505631B (xx)
UY (1) UY25108A1 (xx)
WO (1) WO1999005105A1 (xx)
YU (1) YU2200A (xx)
ZA (1) ZA986475B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402336C (en) * 2000-04-03 2008-03-11 F. Hoffmann-La Roche Ag Concentrated solutions of carvedilol
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
IL153688A0 (en) 2000-06-28 2003-07-06 Teva Pharma Carvedilol
EP1406614B1 (en) * 2001-07-13 2006-06-07 Smithkline Beecham Corporation Carvedilol polymorph
EP1929998A3 (en) 2001-09-21 2008-11-26 Egalet A/S Controlled release solid dispersions of carvedilol
RU2308449C2 (ru) * 2001-09-28 2007-10-20 Ф.Хоффманн-Ля Рош Аг Псевдополиморфные формы карведилола
CN1298322C (zh) * 2002-01-15 2007-02-07 特瓦制药工业有限公司 卡维地洛的结晶固体及其制备方法
CA2483054A1 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
EP1539140A4 (en) 2002-06-27 2005-12-07 Sb Pharmco Inc CARVEDILOLHYDOBROMID
BR0312102A (pt) 2002-06-27 2007-05-29 Sb Pharmco Inc sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento
US20040151772A1 (en) 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
DK1838670T3 (da) * 2004-12-09 2010-03-01 Zach System Spa Fremgangsmåde til fremstilling af carvedilol og dets enantiomere
EP1781611A1 (en) * 2005-06-09 2007-05-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
US8022094B2 (en) 2006-06-28 2011-09-20 Teva Pharmaceutical Industries Ltd. Carvedilol phosphate
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
YU2200A (sh) 2002-03-18
EP1000027B1 (en) 2003-04-02
NO313588B1 (no) 2002-10-28
ES2195366T3 (es) 2003-12-01
CA2296637C (en) 2005-11-15
ATE236123T1 (de) 2003-04-15
AR015133A1 (es) 2001-04-18
CZ2000221A3 (cs) 2000-05-17
MY117734A (en) 2004-07-31
PE96999A1 (es) 1999-10-12
BR9810776A (pt) 2000-09-19
CA2296637A1 (en) 1999-02-04
EP0893440A1 (en) 1999-01-27
HK1029339A1 (en) 2001-03-30
HUP0003198A3 (en) 2002-10-28
DE69812964D1 (de) 2003-05-08
KR20010022097A (ko) 2001-03-15
MA26523A1 (fr) 2004-12-20
PT1000027E (pt) 2003-07-31
RU2202542C2 (ru) 2003-04-20
IL133677A (en) 2004-06-01
NO20000301L (no) 2000-01-21
NZ502136A (en) 2002-05-31
HRP980406A2 (en) 1999-04-30
JP2001510824A (ja) 2001-08-07
NO20000301D0 (no) 2000-01-21
TR200000148T2 (tr) 2000-07-21
PL338432A1 (en) 2000-11-06
CZ296947B6 (cs) 2006-08-16
AU8631998A (en) 1999-02-16
PL191602B1 (pl) 2006-06-30
DE69812964T2 (de) 2004-03-04
WO1999005105A1 (en) 1999-02-04
TW505631B (en) 2002-10-11
DK1000027T3 (da) 2003-07-21
KR100336229B1 (ko) 2002-05-09
EP1000027A1 (en) 2000-05-17
CN1264366A (zh) 2000-08-23
HUP0003198A2 (en) 2001-03-28
ZA986475B (en) 2000-01-21
UY25108A1 (es) 2000-12-29
AU740453B2 (en) 2001-11-01
IL133677A0 (en) 2001-04-30
CN1125047C (zh) 2003-10-22

Similar Documents

Publication Publication Date Title
SI1000027T1 (en) Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
HUP0203257A3 (en) Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them
HUP0001943A3 (en) Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them
HUP0100225A3 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
HUP0100431A3 (en) Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them
IL120699A0 (en) Indole derivatives and pharmaceutical compositions containing them
HUP9802422A3 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
HUP9801044A3 (en) Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP9801045A3 (en) Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation
HUP0200309A2 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
HUP0001541A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
HUP0002830A3 (en) Indole and 2,3-dihydroindole derivatives, their preparation, use, and pharmaceutical compositions containing them
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
IL112627A0 (en) Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
HUP9802121A3 (en) Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003053A3 (en) Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them
ZA983997B (en) Triazole derivatives, process for their preparation and pharmaceutical compositions containing them.
AU9416201A (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
EE04778B1 (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0004294A3 (en) Indole derivatives, pharmaceutical compositions containing them and process for producing them
HUP0001773A3 (en) Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them